This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Quotient Biodiagnostics, Inc.
Quotient Biodiagnostics, Inc., a leading player in the biotechnology sector, is headquartered in the United States. Founded in 2012, the company has rapidly established itself in the field of blood diagnostics, focusing on innovative solutions for transfusion medicine. With a commitment to enhancing patient safety, Quotient offers unique products such as the MosaiQ™ platform, which streamlines blood grouping and antibody screening processes. The company operates primarily in North America and Europe, positioning itself as a key provider of advanced diagnostic technologies. Notable achievements include regulatory approvals that have bolstered its market presence. Quotient Biodiagnostics continues to set itself apart through its dedication to quality and innovation, making significant strides in the evolving landscape of medical diagnostics.
DitchCarbon Score
How does Quotient Biodiagnostics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Quotient Biodiagnostics, Inc.'s score of 18 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Quotient Biodiagnostics, Inc.'s reported carbon emissions
Quotient Biodiagnostics, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As a current subsidiary, Quotient Biodiagnostics may inherit climate commitments or emissions data from its parent organisation; however, no specific details have been provided regarding such cascaded information. The company appears to be in the early stages of establishing its climate strategy and emissions reporting framework. In the context of the industry, it is essential for companies like Quotient Biodiagnostics to develop robust climate commitments and reduction initiatives to align with global sustainability goals and respond to increasing regulatory and consumer expectations regarding environmental responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Quotient Biodiagnostics, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
